Product Overview

Defcort 12 mg is a pharmaceutical preparation that contains the corticosteroid deflazacort as the active ingredient. It is formulated for oral administration and is supplied in tablet form, with each strip containing ten tablets. The product is manufactured by Macleods Pharmaceuticals Pvt Ltd, a company recognized for its commitment to quality and regulatory compliance in the Indian and international pharmaceutical markets. Packaged in strengths of 12 mg per tablet, Defcort is indicated for the treatment of severe allergic reactions, providing patients with a potent anti‑inflammatory option when standard therapies are insufficient. The medication is available in pack sizes of 30, 60, and 90 tablets, allowing flexibility for both short‑term and chronic treatment regimens. Delivery typically occurs within six to fifteen days, depending on the shipping destination and local pharmacy logistics.

What is Defcort 12 mg (Deflazacort)

Deflazacort belongs to the class of glucocorticoid steroids and exerts its therapeutic effect by modulating the body’s immune response. Unlike some other corticosteroids, deflazacort is associated with a relatively favorable side‑effect profile, making it a preferred choice for long‑term management of inflammatory conditions. The drug functions by binding to intracellular glucocorticoid receptors, which subsequently influences gene transcription pathways that regulate inflammation, immune cell migration, and allergic symptomatology. This mechanism enables Defcort to reduce swelling, redness, and itching associated with severe hypersensitivity reactions. For a detailed scientific overview, refer to the Wikipedia entry on deflazacort, which provides a comprehensive summary of its pharmacology.

Uses and Benefits

Clinically, Defcort 12 mg is employed when patients experience acute or chronic severe allergic reactions that do not respond adequately to antihistamines or topical agents. Its anti‑inflammatory potency makes it effective for conditions such as acute urticaria, angioedema, and allergic dermatitis. In addition, the medication is sometimes prescribed for autoimmune skin disorders that have an allergic component, including eczema and psoriasis flares triggered by environmental factors. The benefits of using Defcort include rapid symptom control, reduction in the need for rescue medications, and improved quality of life for individuals with recurrent hypersensitivity episodes. Because the drug is available in various pack sizes, patients can tailor their purchase to the expected duration of therapy, which is especially helpful for those requiring a structured treatment course.

How It Works

The pharmacological action of deflazacort centers on its ability to suppress the cascade of inflammatory mediators that are released during an allergic response. Upon ingestion, the drug is absorbed in the gastrointestinal tract and undergoes hepatic metabolism, converting it into its active form that circulates systemically. Once bound to glucocorticoid receptors, deflazacort inhibits the production of prostaglandins and leukotrienes, two key chemicals responsible for vasodilation and increased vascular permeability. This inhibition leads to a decrease in capillary leakage and smooth‑muscle contraction, thereby alleviating swelling and itching. Moreover, deflazacort stabilizes mast cells, reducing the release of histamine and other allergy‑mediating substances. For an evidence‑based explanation of corticosteroid mechanisms, see the National Institutes of Health (NIH) resource on glucocorticoid action.

Dosage Guidelines

Defcort 12 mg tablets are intended for oral use and should be taken exactly as directed by a qualified healthcare professional. Typical treatment regimens involve a single daily dose, although the precise schedule may vary based on the severity of the allergic condition and the patient’s overall health status. Patients are advised to swallow the tablet whole with water and to avoid crushing or chewing it, as this could affect the drug’s absorption profile. It is important to complete the full prescribed course, even if symptoms improve early, to prevent recurrence of the allergic reaction. In the event of a missed dose, the patient should take it as soon as remembered unless it is close to the time of the next scheduled dose; in such cases, the missed dose should be skipped to avoid overdose. Always consult a physician for personalized dosing instructions, especially when the medication is used in pediatric populations or in individuals with hepatic impairment.

Side Effects

Like all corticosteroids, Defcort 12 mg can produce adverse effects, although many users experience only mild or transient symptoms. Common side effects include increased appetite, mild weight gain, and temporary sleep disturbances. Some individuals may report gastrointestinal discomfort, such as heartburn or nausea. Less frequently, the medication can cause elevated blood pressure, changes in blood glucose levels, or mood alterations. Rare but serious adverse reactions include signs of infection, severe allergic reactions to the drug itself, or dermatological conditions such as facial swelling. If any of these symptoms persist or worsen, medical attention should be sought immediately. For a comprehensive list of reported side effects, refer to the Drugs.com monograph, which aggregates data from clinical studies and post‑marketing surveillance.

Warnings and Precautions

Before initiating therapy with Defcort, patients should disclose their full medical history to their prescribing clinician, particularly any history of hypertension, diabetes, osteoporosis, or psychiatric disorders. The drug is contraindicated in individuals with known hypersensitivity to deflazacort or any of its excipients. Concurrent use of live vaccines is generally discouraged during high‑dose corticosteroid therapy, as immune suppression may reduce vaccine efficacy. Pregnant or breastfeeding women should use Defcort only if the anticipated benefit outweighs potential risks, and they must discuss this with their obstetric provider. Patients are advised to avoid alcohol consumption while on treatment, as it may exacerbate liver strain. Additionally, abrupt discontinuation of the medication is not recommended; tapering should be performed under medical supervision to prevent adrenal insufficiency. For further guidance on corticosteroid safety, consult the MedlinePlus drug information page.

Frequently Asked Questions

1. What is the primary indication for Defcort 12 mg? It is specifically indicated for the treatment of severe allergic reactions, including acute urticaria, angioedema, and other hypersensitivity disorders that require systemic anti‑inflammatory therapy.
2. How should Defcort be stored? Store the tablets at room temperature, away from moisture and direct sunlight. Keep the medication out of reach of children and pets.
3. Can Defcort be taken with other allergy medications? Yes, it can be used in combination with antihistamines or topical agents, but the overall treatment plan should be coordinated with a healthcare professional to avoid drug interactions.
4. Is Defcort safe for long‑term use? Long‑term use is possible under medical supervision, but regular monitoring of blood pressure, blood glucose, and bone density is recommended to mitigate potential chronic side effects.
5. Where can I verify the authenticity of Defcort manufactured by Macleods? Authentic products bear the manufacturer’s label, batch number, and expiry date. Purchasing from licensed pharmacies or verified online retailers ensures product integrity.

Related Products

• Defcort (Deflazacort)
• Defcort 6 mg (Deflazacort)
• Defcort 18 mg (Deflazacort)
• Defcort 24 mg (Deflazacort)
• Defcort 30 mg (Deflazacort)
• Megalis Tablet (Tadalafil)
• Megalis 20 mg (Tadalafil)
• Omnacortil (Prednisolone)
• Omnacortil 5mg (Prednisolone)
• Omnacortil 10 mg (Prednisolone)
• Omnacortil 20 mg DT (Dispersible Tablets)
• Omnacortil 30 mg (Prednisolone)